Back to search
FDAFDA · Food and drugs·Recall number D-1059-2014

Glipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by: Greenstone Ltd., Peapack, NJ --- NDC 59762-5032-2

Published February 12, 2014 · Recall initiated: November 4, 2013

Summary

FDA records drug Class III recall D-1059-2014, published February 12, 2014 and initiated November 4, 2013. Recalling firm: Greenstone Llc; Status: Terminated; Reported quantity: 22,529 bottles; Lot: lot V112000, EXP Jun 2016. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Greenstone Llc
Distributor
US Nationwide (including PR)
Lot
lot V112000, EXP Jun 2016
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Glipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by: Greenstone Ltd., Peapack, NJ --- NDC 59762-5032-2 recalled?

Yes. FDA published recall D-1059-2014 on February 12, 2014. Reported hazard: Failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval

What should I do if I have this product?

Voluntary: Firm initiated · Letter